- The report contains detailed information about Neuralstem Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Neuralstem Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Neuralstem Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Neuralstem Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Neuralstem Inc. business.
About Neuralstem Inc.
Neuralstem, Inc., a biopharmaceuticals company, focuses on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs.
The company has developed and maintains a portfolio of patents and patent applications that form the proprietary base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies. With respect to the human neural stem cells, the company has developed proprietary and reproducible processes to identify, isolate, expand, and control cell differentiation in mature functioning human neurons1 and glia2 and bank human neural stem cells derived from brain tissue.
The company utilizes its proprietary human neural stem cell technology to create a platform for the treatment of central nervous system diseases. It would commercialize this technology as a tool for use in the next generation of small-molecule drug discovery and to create cell therapy biotherapeutics to treat central nervous system diseases for which there are no cures. It also intends to develop and commercialize products for use in treatment of various neurodegenerative conditions and in regenerative repair of acute disease.
The companys technology includes the ability to isolate human neural stem cells from major areas of the human brain and spinal cord and to grow them into physiologically relevant human neurons of all types. Its core patents entitled: isolation, propagation, and directed differentiation of stem cell from embryonic and adult central nervous system of mammal; and in vitro generation of differentiated neurons from cultures of mammalian multi-potential CNS stem cell, contain claims which cover the details of this process and the culture of cells created. The company is also working on the following additional indications for its technologies: stroke; Huntingtons disease; and amyotrophic lateral sclerosis (ALS).
Neuralstem, Inc. was founded in 1996.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. NEURALSTEM INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. NEURALSTEM INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. NEURALSTEM INC. SWOT ANALYSIS
4. NEURALSTEM INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. NEURALSTEM INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Neuralstem Inc. Direct Competitors
5.2. Comparison of Neuralstem Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Neuralstem Inc. and Direct Competitors Stock Charts
5.4. Neuralstem Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Neuralstem Inc. Industry Position Analysis
6. NEURALSTEM INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. NEURALSTEM INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. NEURALSTEM INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. NEURALSTEM INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. NEURALSTEM INC. PORTER FIVE FORCES ANALYSIS2
12. NEURALSTEM INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Neuralstem Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Neuralstem Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Neuralstem Inc. Major Shareholders
Neuralstem Inc. History
Neuralstem Inc. Products
Revenues by Segment
Revenues by Region
Neuralstem Inc. Offices and Representations
Neuralstem Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Neuralstem Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Neuralstem Inc. Capital Market Snapshot
Neuralstem Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Neuralstem Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Neuralstem Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Neuralstem Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Neuralstem Inc. 1-year Stock Charts
Neuralstem Inc. 5-year Stock Charts
Neuralstem Inc. vs. Main Indexes 1-year Stock Chart
Neuralstem Inc. vs. Direct Competitors 1-year Stock Charts
Neuralstem Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?